79 related articles for article (PubMed ID: 2284161)
1. Increased hGH production rate after low-dose estrogen therapy in prepubertal girls with Turner's syndrome.
Mauras N; Rogol AD; Veldhuis JD
Pediatr Res; 1990 Dec; 28(6):626-30. PubMed ID: 2284161
[TBL] [Abstract][Full Text] [Related]
2. Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicle-stimulating hormone, and luteinizing hormone in prepubertal girls with Turner's syndrome.
Mauras N; Rogol AD; Veldhuis JD
J Clin Endocrinol Metab; 1989 Nov; 69(5):1053-8. PubMed ID: 2507569
[TBL] [Abstract][Full Text] [Related]
3. The effect of short term treatment with growth hormone and ethinyl estradiol on lower leg growth rate in girls with Turner's syndrome.
Ross JL; Cassorla F; Carpenter G; Long LM; Royster MS; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1988 Sep; 67(3):515-8. PubMed ID: 3410937
[TBL] [Abstract][Full Text] [Related]
4. Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner's syndrome.
Vanderschueren-Lodeweyckx M; Massa G; Maes M; Craen M; van Vliet G; Heinrichs C; Malvaux P
J Clin Endocrinol Metab; 1990 Jan; 70(1):122-6. PubMed ID: 2294126
[TBL] [Abstract][Full Text] [Related]
5. Decreased metabolic clearance of endogenous growth hormone and specific alterations in the pulsatile mode of growth hormone secretion occur in prepubertal girls with Turner's syndrome. Genentech Collaborative Group.
Veldhuis JD; Sotos JF; Sherman BM
J Clin Endocrinol Metab; 1991 Nov; 73(5):1073-80. PubMed ID: 1939522
[TBL] [Abstract][Full Text] [Related]
6. Effects of acute high dose and chronic low dose estrogen on plasma somatomedin-C and growth in patients with Turner's syndrome.
Copeland KC
J Clin Endocrinol Metab; 1988 Jun; 66(6):1278-82. PubMed ID: 3372687
[TBL] [Abstract][Full Text] [Related]
7. Growth in Turner's syndrome: long term treatment with low dose ethinyl estradiol.
Martínez A; Heinrich JJ; Domené H; Escobar ME; Jasper H; Montuori E; Bergadá G
J Clin Endocrinol Metab; 1987 Aug; 65(2):253-7. PubMed ID: 3597706
[TBL] [Abstract][Full Text] [Related]
8. Plasma growth hormone-binding protein activity, insulin-like growth factor I, and its binding protein levels in patients with Turner's syndrome: effect of short- and long-term recombinant human growth hormone administration.
Saggese G; Federico G; Cinquanta L
Pediatr Res; 1995 Jan; 37(1):106-11. PubMed ID: 7535419
[TBL] [Abstract][Full Text] [Related]
9. [The current treatment concept of Turner syndrome].
Blümel P; Stögmann W
Padiatr Padol; 1989; 24(1):81-9. PubMed ID: 2654820
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of girls with Turner's syndrome with growth hormone and estrogen--1-year experiences].
Naeraa RW; Nielsen J; Kastrup KW
Ugeskr Laeger; 1992 Jun; 154(25):1773-8. PubMed ID: 1632017
[TBL] [Abstract][Full Text] [Related]
11. [Growth hormone for Turner's syndrome].
Fishman A; Hochberg Z
Harefuah; 1991 Nov; 121(9):281-6. PubMed ID: 1800273
[TBL] [Abstract][Full Text] [Related]
12. Estrogen therapy enhances calcium absorption and retention and diminishes bone turnover in young girls with Turner's syndrome: a calcium kinetic study.
Mauras N; Vieira NE; Yergey AL
Metabolism; 1997 Aug; 46(8):908-13. PubMed ID: 9258273
[TBL] [Abstract][Full Text] [Related]
13. Comparison of transdermal and oral estrogen therapy in girls with Turner's syndrome.
Jospe N; Orlowski CC; Furlanetto RW
J Pediatr Endocrinol Metab; 1995; 8(2):111-6. PubMed ID: 7584704
[TBL] [Abstract][Full Text] [Related]
14. Testosterone-estradiol-binding globulin in patients with Turner's syndrome: effects of estrogens and acute growth hormone administration.
Bergink EW; Wolf DL; Wittliff JL; Bruining GJ; Bryson MF; Forbes GB
J Clin Endocrinol Metab; 1976 Jun; 42(6):1018-23. PubMed ID: 180042
[TBL] [Abstract][Full Text] [Related]
15. Estrogen therapy in Turner's syndrome.
Cutler GB; Ross JL
Acta Paediatr Jpn; 1992 Apr; 34(2):195-202; discussion 202-5. PubMed ID: 1621525
[TBL] [Abstract][Full Text] [Related]
16. [Effect of mestranol and chlormadinone acetate on HGH secretion in Turner's syndrome].
Rudolf K; Kunkel S; Woltanski KP
Zentralbl Gynakol; 1985; 107(23):1454-9. PubMed ID: 2420102
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone secretion in Turner's syndrome and influence of oxandrolone and ethinyl oestradiol.
Massarano AA; Brook CG; Hindmarsh PC; Pringle PJ; Teale JD; Stanhope R; Preece MA
Arch Dis Child; 1989 Apr; 64(4):587-92. PubMed ID: 2751332
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone secretion in patients with Turner's syndrome as determined by time series analysis.
Wit JM; Massarano AA; Kamp GA; Hindmarsh PC; van Es A; Brook CG; Preece MA; Matthews DR
Acta Endocrinol (Copenh); 1992 Jul; 127(1):7-12. PubMed ID: 1519426
[TBL] [Abstract][Full Text] [Related]
19. A preliminary study of the effect of estrogen dose on growth in Turner's syndrome.
Ross JL; Cassorla FG; Skerda MC; Valk IM; Loriaux DL; Cutler GB
N Engl J Med; 1983 Nov; 309(18):1104-6. PubMed ID: 6684731
[No Abstract] [Full Text] [Related]
20. The interaction of growth hormone, somatomedin and oestrogen in patients with Turner's syndrome.
Saenger P; Schwartz E; Wiedemann E; Levine LS; Tsai M; New MI
Acta Endocrinol (Copenh); 1976 Jan; 81(1):9-18. PubMed ID: 946143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
